HHSN26100006 TORFP 2014-3I Evaluation of the Prevention by Actoplus/Met (Pioglitazone and Metformin) of ER+ and ER- Mammary Cancer Occurring in Rodents on a High-Fat Diet

Grant

Date/time Interval

  • September 12, 2014 - September 11, 2017
  • Total Award Amount

  • 489093.00
  • Direct Costs

  • 332717.00
  • Sponsor Award Id

  • HHSN261201200021I
  • Contributor

  • Grubbs Ph.D., Clinton   Principal Investigator  
  • Juliana, M   Investigator